Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;43(1):354-366.
doi: 10.1002/hed.26485. Epub 2020 Sep 30.

Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review

Affiliations
Review

Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review

Michaela Svajdova et al. Head Neck. 2021 Jan.

Abstract

Management of patients with recurrent head and neck cancer remains a challenge for the surgeon as well as the treating radiation oncologist. Even in the era of modern radiotherapy, the rate of severe toxicity remains high with unsatisfactory treatment results. Intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and heavy-ion irradiation have all emerged as highly conformal and precise techniques that offer many radiobiological advantages in various clinical situations. Although re-irradiation is now widespread in clinical practice, little is known about the differences in treatment response and toxicity using diverse re-irradiation techniques. In this review, we provide a comprehensive overview of the role of radiation therapy in recurrent or second primary head and neck cancer including patient selection, therapeutic outcome, and risk using different re-irradiation techniques. Critical review of published evidence on IMRT, SBRT, and heavy-ion full-dose re-irradiation is presented including data on locoregional control, overall survival, and toxicity.

Keywords: head and neck cancer; radiotherapy; re-irradiation; recurrence; toxicity.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Coatesworth AP, Tsikoudas A, MacLennan K. The cause of death in patients with head and neck squamous cell carcinoma. J Laryngol Otol. 2002;116(4):269-271.
    1. Lambrecht M, Dirix P, Van den Bogaert W, Nuyts S. Incidence of isolated regional recurrence after definitive (chemo) radiotherapy for head and neck squamous cell carcinoma. Radiother Oncol. 2009;93:498-502.
    1. Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer. Cancer. 2014;120:1507-1513.
    1. Bourhis J, Le Maître A, Baujat B, et al. Individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol. 2007;19:188-194.
    1. Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337 patient, multi-institutional experience. Ann Oncol. 2004;15(8):1179-1186.

Publication types

MeSH terms

LinkOut - more resources